ArticleNeurology(R) neuroimmunology & neuroinflammation2025
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study.
Frauke Stascheit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled itcites it